Unknown

Dataset Information

0

De novo mutations in ataxin-2 gene and ALS risk.

ABSTRACT: Pathogenic CAG repeat expansion in the ataxin-2 gene (ATXN2) is the genetic cause of spinocerebellar ataxia type 2 (SCA2). Recently, it has been associated with Parkinsonism and increased genetic risk for amyotrophic lateral sclerosis (ALS). Here we report the association of de novo mutations in ATXN2 with autosomal dominant ALS. These findings support our previous conjectures based on population studies on the role of large normal ATXN2 alleles as the source for new mutations being involved in neurodegenerative pathologies associated with CAG expansions. The de novo mutations expanded from ALS/SCA2 non-risk alleles as proven by meta-analysis method. The ALS risk was associated with SCA2 alleles as well as with intermediate CAG lengths in the ATXN2. Higher risk for ALS was associated with pathogenic CAG repeat as revealed by meta-analysis.

SUBMITTER: Laffita-Mesa JM 

PROVIDER: S-EPMC3735591 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Pathogenic CAG repeat expansion in the ataxin-2 gene (ATXN2) is the genetic cause of spinocerebellar ataxia type 2 (SCA2). Recently, it has been associated with Parkinsonism and increased genetic risk for amyotrophic lateral sclerosis (ALS). Here we report the association of de novo mutations in ATXN2 with autosomal dominant ALS. These findings support our previous conjectures based on population studies on the role of large normal ATXN2 alleles as the source for new mutations being involved in  ...[more]

Similar Datasets

Unknown Exome sequencing to identify de novo mutations in sporadic ALS trios.
| S-EPMC3709464 | biostudies-literature
Unknown Recurrent de novo mutations implicate novel genes underlying simplex autism risk.
| S-EPMC4249945 | biostudies-literature
Unknown Paternal-age-related de novo mutations and risk for five disorders.
| S-EPMC6620346 | biostudies-literature
Unknown A de novo missense mutation of the FUS gene in a "true" sporadic ALS case.
| S-EPMC2972379 | biostudies-literature
Unknown Canalization by Selection of de Novo Induced Mutations.
| S-EPMC5560803 | biostudies-other
Unknown De novo mutations in epileptic encephalopathies.
| S-EPMC3773011 | biostudies-literature
Unknown De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy.
| S-EPMC5972584 | biostudies-literature
Unknown Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
| S-EPMC2965417 | biostudies-literature
Unknown De novo KCNB1 mutations in epileptic encephalopathy.
| S-EPMC4192091 | biostudies-literature
Unknown TUBB4A de novo mutations cause isolated hypomyelination.
| S-EPMC4153852 | biostudies-literature